Dr Liliana Galindo MD PhD

I am an Affiliated Assistant Professor of Psychiatry, CPFT's Medical Leader in Psychosis, and a consultant psychiatrist for the Trust's CAMEO early intervention service. My research over the past decade has focused on the study and integration of altered states of mind: Psychedelic Research (and other psychoactive substances) and Early Psychosis. I am interested in studying the psychoactive effects of substances, including therapeutical use, as well as understanding their effects on the development of psychopathology. I am leading the first two local clinical trials of Psychedelic-Assisted Therapy with a multisdisciplinary team composed of CPFT Cambridge University Hospitals and researchers from Cambridge University. I co-lead locally the Psychosis Risk Outcomes NETwork (ProNET), a global effort led by Yale University to improve prevention and treatment for clinical high-risk psychosis. I co-facilitate Conversations with Experts by Experience (CEbE) sessions led by people with lived experience of mental health challenges, for researchers and PhD students studying mental health conditions.